Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

2018 Genitourinary Cancers Symposium /
Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumour patients

8th - 10th Feb 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 08.02.18
Views: 2421
Rating:

Dr Ricardo Leão - University of Toronto, Toronto, Canada

Dr Leão speaks with ecancer at the 2018 ASCO Genitourinary Cancers Symposium about the use of serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumour patients.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation